MNTA is able to copy copaxone and characterize the entire structure. Why did FDA approve teva's copaxone if they did not know the MOA? Why should FDA carry about MOA when MNTA will copy the strucutre and deliver sameness - hence a fully substitutable generic?????????????????????????????????